Tilman Schlothauer

Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions

Tilman Schlothauer, Sylvia Herter, Claudia Ferrara et al. · Protein Engineering Design and Selection · 2016 · 388 citations · Full text

Immunology, Immune Regulation, Immunodominance +24

In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

Marco Thomann, Tilman Schlothauer, Tetyana Dashivets et al. · PLoS ONE · 2015 · 213 citations · Full text

Glycobiology, Immunology, Vitro Glycoengineering +23

MecA, an adaptor protein necessary for ClpC chaperone activity

Tilman Schlothauer, Axel Mogk, David A. Dougan et al. · Proceedings of the National Academy of Sciences · 2003 · 164 citations · Full text

Assessment of chemical modifications of sites in the CDRs of recombinant antibodies

Markus Haberger, Katrin Bomans, Katharina Diepold et al. · mAbs · 2014 · 156 citations · Full text

Immunocytochemical Technique, Immunology, Glycobiology +20

Adaptor protein controlled oligomerization activates the AAA+ protein ClpC

Janine Kirstein, Tilman Schlothauer, David A. Dougan et al. · The EMBO Journal · 2006 · 146 citations · Full text

Protein Function, Protein Assembly, Natural Sciences +3